Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
ASAIO J ; 38(3): M216-9, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1457851

RESUMO

The Novacor (Baxter Novacor, Oakland, CA) Left Ventricular Assist System (LVAS) incorporates a versatile microprocessor based controller that permits a variety of operating modes. These include internally triggered automatic synchronous counterpulsation, electrocardiogram triggered synchronous operation, and full to empty or fixed rate asynchronous operation. The aim of this pilot study was to determine the extent to which washing of the blood contacting surfaces of the pump may be optimized by suitable choice of operating mode. Visualization of flow fields adjacent to surfaces in confined areas requires small, neutrally buoyant tracer particles for feature extraction. A novel technique using fluorescent tracer particles (100 microns), an argon laser, and a low pass optical filter has been developed for this purpose. Particle motion was tracked from video images and calculations were made of velocity. Flow visualization was performed under conditions that simulated clinically observed hemodynamic conditions, typical of the immediate post-implant period. At a given LVAS output, fluid speed in the vicinity of the inflow valve tended to increase at higher LVAS beat rates (and consequently lower LVAS stroke volumes). This and future work may well be useful in selecting the optimum modes of LVAS operation as a function of the hemodynamic status of the patient.


Assuntos
Coração Auxiliar , Velocidade do Fluxo Sanguíneo , Estudos de Avaliação como Assunto , Frequência Cardíaca , Humanos , Fluxometria por Laser-Doppler , Fluxo Sanguíneo Regional , Volume Sistólico
2.
ASAIO J ; 41(3): M665-9, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8573888

RESUMO

Thrombus formation within artificial organs has been shown, at least in part, to be caused by retarded or stagnant blood flow. The goal of this work was to develop a magnifying fiber optic probe capable of visualizing particle flow and cellular deposition in a physiologically relevant cellular suspension (blood). The probe has minimal cross sectional area to allow for access to confined areas and to minimize flow disturbance. The probe consists of a germanium oxide fiber optic bundle and a gradient index imaging lens. Fluorescent microspheres of 48 microns, 7 microns, and 3 microns in diameter were imaged after deposition on to a cover slip. The flow (1.44 mm/sec) of 3 microns microspheres suspended in buffer alone and with red cell hematocrits of 10%, 25% and 45% were also visualized. To investigate the potential for this probe to detect ongoing thrombosis, fluorescently labeled human platelets were observed depositing on surfaces from a stagnant platelet rich buffer. These initial data suggest that this probe may offer a technique for the visualization of blood cell adhesion on the interior of artificial organs and the local quantification of flow in such devices.


Assuntos
Tecnologia de Fibra Óptica/instrumentação , Órgãos Artificiais/efeitos adversos , Células Sanguíneas/citologia , Adesão Celular , Hematócrito , Hemorreologia/instrumentação , Humanos , Técnicas In Vitro , Microscopia de Fluorescência , Microesferas , Fibras Ópticas , Adesividade Plaquetária , Soluções , Trombose/sangue , Trombose/diagnóstico , Trombose/etiologia
3.
J Biomed Mater Res ; 49(4): 460-8, 2000 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-10602079

RESUMO

The degree of platelet adhesion and subsequent thrombus formation is an important measure of biocompatibility for cardiovascular biomaterials. Traditional methods of quantifying platelet adhesion often are limited by the need for direct optical access, limited spatial resolution, or the lack of temporal resolution. We have developed a new imaging system that utilizes fiber optics and fluorescence microscopy for the quantification of platelet adhesion. This fiber optic remote microscope is capable of imaging individual fluorescently labeled platelets in whole blood on opaque surfaces. Using this method, platelet adhesion was quantified on a series of metallic [low-temperature isotropic carbon (LTIC); titanium alloy (Ti); diamond-like carbon (DLC); oxidized titanium alloy (TiO); and polycrystalline diamond (PCD)] and polymeric [woven Dacron (WD)] collagen-impregnated Dacron (HEM), expanded polytetrafluoroethylene (ePTFE), and denucleated ePTFE (dePTFE)] biomaterials designed for use in cardiovascular applications. These materials were perfused with heparinized whole human blood in an in vitro parallel plate flow chamber. Platelet adhesion after 5 min of perfusion ranged from 3.7 +/- 1.0 (dePTFE) to 16.8 +/- 1.5 (WD) platelets/1000 micrometer. The temporal information revealed by these studies provides a comparative measure of the acute thrombogenicity of these materials as well as some insight into their long-term hemocompatibilities. Also studied here were the effects of wall shear rate and axial position on platelet adhesion. A predicted increase in platelet adhesion with increased wall shear rate and a trend toward a decrease in platelet adhesion with increased axial distance was observed with the fiber optic microscope. Future applications for this imaging technique may include the long-term evaluation of thrombosis in blood-contacting devices in vitro and, in animal models, in vivo.


Assuntos
Materiais Biocompatíveis , Microscopia/instrumentação , Adesividade Plaquetária , Ligas , Plaquetas/fisiologia , Plaquetas/ultraestrutura , Carbono , Colágeno , Diamante , Tecnologia de Fibra Óptica , Humanos , Processamento de Imagem Assistida por Computador , Metais , Microscopia/métodos , Microscopia Eletrônica de Varredura , Fibras Ópticas , Polietilenotereftalatos , Politetrafluoretileno , Titânio
4.
J Biomater Sci Polym Ed ; 11(11): 1239-59, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11263811

RESUMO

Ventricular assist devices (VADs) are increasingly applied to support patients with advanced cardiac failure. While the benefit of VADs in supporting this patient group is clear, substantial morbidity and mortality occur during the VAD implant period due to thromboembolic and infective complications. Efforts at the University of Pittsburgh aimed at evaluating the blood biocompatibility of VADs in the clinical, animal, and in vitro setting over the past decade are summarized. Emphasis is placed on understanding the mechanisms of thrombosis and thromboembolism associated with these devices.


Assuntos
Materiais Biocompatíveis/efeitos adversos , Sangue , Coração Auxiliar , Materiais Biocompatíveis/normas , Coagulação Sanguínea/efeitos dos fármacos , Equipamentos e Provisões , Humanos , Trombose/etiologia , Trombose/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA